Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 1
1976 2
1978 2
1979 1
1980 1
1981 1
1982 2
1985 1
1987 2
1988 5
1989 8
1990 5
1991 8
1992 7
1993 7
1994 10
1995 5
1996 8
1997 12
1998 14
1999 13
2000 6
2001 19
2002 15
2003 19
2004 18
2005 21
2006 26
2007 43
2008 29
2009 34
2010 34
2011 38
2012 41
2013 38
2014 45
2015 73
2016 65
2017 77
2018 75
2019 73
2020 91
2021 124
2022 123
2023 120
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

1,225 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric lupus nephritis.
Pinheiro SVB, Dias RF, Fabiano RCG, Araujo SA, Silva ACSE. Pinheiro SVB, et al. J Bras Nefrol. 2019 Apr-Jun;41(2):252-265. doi: 10.1590/2175-8239-JBN-2018-0097. Epub 2018 Nov 14. J Bras Nefrol. 2019. PMID: 30465590 Free PMC article. Review.
Involvement of the kidneys by lupus nephritis (LN) is one of the most severe clinical manifestations seen in individuals with systemic lupus erythematosus (SLE). LN is more frequent and severe in pediatric patients and has been associated with higher m …
Involvement of the kidneys by lupus nephritis (LN) is one of the most severe clinical manifestations seen in individuals with …
Belimumab for the treatment of pediatric patients with lupus nephritis.
Stohl W, Kwok A. Stohl W, et al. Expert Opin Biol Ther. 2023 Mar;23(3):243-251. doi: 10.1080/14712598.2023.2178297. Epub 2023 Feb 17. Expert Opin Biol Ther. 2023. PMID: 36750049 Clinical Trial.
INTRODUCTION: The FDA approved the anti-BAFF monoclonal antibody, belimumab, in 2011 for adult systemic lupus erythematosus (SLE), in 2019 for pediatric SLE, in 2020 for adult lupus nephritis (LN), and in 2022 for pediatric LN. AREAS COVERED: We …
INTRODUCTION: The FDA approved the anti-BAFF monoclonal antibody, belimumab, in 2011 for adult systemic lupus erythematosus (SLE), in …
Pediatric Lupus Nephritis-Review of Literature.
Thakur N, Rai N, Batra P. Thakur N, et al. Curr Rheumatol Rev. 2017;13(1):29-36. doi: 10.2174/1573397112666160404124308. Curr Rheumatol Rev. 2017. PMID: 27041086 Review.
Treatment of lupus nephritis is mostly derived from studies in adults as data on children is still lacking. ...In this review we will be discussing lupus nephritis, its diagnosis, pathogenesis, clinical picture and treatment advancements....
Treatment of lupus nephritis is mostly derived from studies in adults as data on children is still lacking. ...In this review …
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (LN). METHODS: Following the EULAR standardised operating procedures, a systematic literature review was performed. ...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (LN). METHODS: Following th …
Belimumab for systemic lupus erythematosus - Focus on lupus nephritis.
Plüß M, Piantoni S, Tampe B, Kim AHJ, Korsten P. Plüß M, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2072143. doi: 10.1080/21645515.2022.2072143. Epub 2022 May 19. Hum Vaccin Immunother. 2022. PMID: 35588699 Free PMC article. Review.
In recent years, advances in the treatment and management of patients with systemic lupus erythematosus (SLE) have improved their life expectancy and quality of life. However, lupus nephritis (LN) still represents a major life-threatening complication of the …
In recent years, advances in the treatment and management of patients with systemic lupus erythematosus (SLE) have improved their lif …
The immune cell landscape in kidneys of patients with lupus nephritis.
Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network. Arazi A, et al. Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. Nat Immunol. 2019. PMID: 31209404 Free PMC article.
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy contr …
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To d …
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort.
Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB; CARRA Registry investigators. Vazzana KM, et al. Lupus. 2021 Sep;30(10):1660-1670. doi: 10.1177/09612033211028658. Epub 2021 Jul 4. Lupus. 2021. PMID: 34219529 Free PMC article. Review.
Lupus nephritis (LN) is a life-threatening manifestation of systemic lupus erythematosus (SLE) and is more common in children than adults. ...
Lupus nephritis (LN) is a life-threatening manifestation of systemic lupus erythematosus (SLE) and is more common in ch …
Recent advances in immunotherapies for lupus nephritis.
Kaneko M, Jackson SW. Kaneko M, et al. Pediatr Nephrol. 2023 Apr;38(4):1001-1012. doi: 10.1007/s00467-022-05670-7. Epub 2022 Jul 1. Pediatr Nephrol. 2023. PMID: 35778517 Free PMC article. Review.
Childhood-onset systemic lupus erythematosus (SLE) is characterized by increased rates of kidney involvement, termed lupus nephritis. ...Future studies are needed to define optimal patient selection, drug combinations, and treatment duration in pediatric …
Childhood-onset systemic lupus erythematosus (SLE) is characterized by increased rates of kidney involvement, termed lupus …
Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.
Tanaka H, Joh K, Imaizumi T. Tanaka H, et al. Clin Exp Nephrol. 2017 Oct;21(5):755-763. doi: 10.1007/s10157-017-1381-1. Epub 2017 Mar 3. Clin Exp Nephrol. 2017. PMID: 28258497 Review.
Lupus nephritis (LN) is one of the major clinical manifestations of systemic lupus erythematosus (SLE) which occurs frequently in the early stages of pediatric-onset cases. ...
Lupus nephritis (LN) is one of the major clinical manifestations of systemic lupus erythematosus (SLE) which occurs fre …
Kidney outcomes for children with lupus nephritis.
Oni L, Wright RD, Marks S, Beresford MW, Tullus K. Oni L, et al. Pediatr Nephrol. 2021 Jun;36(6):1377-1385. doi: 10.1007/s00467-020-04686-1. Epub 2020 Jul 28. Pediatr Nephrol. 2021. PMID: 32725543 Free PMC article. Review.
Systemic lupus erythematosus is a rare lifelong multi-systemic autoimmune condition. ...The rate of CKD 5 is reported to be up to 15% and the presence of lupus nephritis (LN) has an established link with an associated increase in mortality. ...
Systemic lupus erythematosus is a rare lifelong multi-systemic autoimmune condition. ...The rate of CKD 5 is reported to be up to 15% …
1,225 results

Searches related to "pediatric lupus nephritis"